Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aprea Therapeutics, Inc. | 259,246 | reported | 28 Jul 2022 | tx 19+1,583,885−87,414 |
| NRG ENERGY, INC. | 34,916 | reported | 29 Mar 2011 | tx 7+122,000−4,884 |
| Omega Therapeutics, Inc. | 25,000 | reported | 20 Jun 2024 | tx 4+611,274 |
| INTEGRA LIFESCIENCES HOLDINGS CORP | 17,700 | reported | 07 May 2026 | tx 47+200,732−99,947 |
| Omthera Pharmaceuticals, Inc. | 0 | reported | 18 Jul 2013 | tx 5+377,615−658,185 |
| MEDAREX INC | 0 | reported | 01 Sept 2009 | tx 54+4,066,695.95−2,003,414 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 17,700 | 0.00 USD | deriv |
| 09 May 2025 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 6,939 | 0.00 USD | |
| 09 May 2025 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 19,592 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | Omega Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 09 May 2024 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 8,696 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Omega Therapeutics, Inc. | 512,848 | 0.00 USD | deriv |
| 10 Jul 2023 | GRANT_AWARD | Omega Therapeutics, Inc. | 36,713 | 0.00 USD | deriv |
| 12 May 2023 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 4,486 | 0.00 USD | |
| 28 Jul 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 32,400 | 0.00 USD | |
| 28 Jul 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 47,600 | 0.00 USD | deriv |
| 03 Jun 2022 | TAX_WITHHOLDING | Aprea Therapeutics, Inc. | 65,770 | 0.81 USD | |
| 18 May 2022 | PURCHASE | Aprea Therapeutics, Inc. | 37,500 | 0.64 USD | first after silence |
| 13 May 2022 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 3,456 | 0.00 USD | |
| 13 May 2022 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 1,265 | 0.00 USD | |
| 10 Mar 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 100,100 | 0.00 USD | |
| 10 Mar 2022 | GRANT_AWARD | Aprea Therapeutics, Inc. | 427,700 | 0.00 USD | deriv |
| 25 Feb 2022 | TAX_WITHHOLDING | Aprea Therapeutics, Inc. | 21,644 | 1.74 USD | |
| 14 May 2021 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 2,896 | 0.00 USD | |
| 14 May 2021 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 530 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Aprea Therapeutics, Inc. | 77,000 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Aprea Therapeutics, Inc. | 88,500 | 0.00 USD | |
| 25 Feb 2021 | GRANT_AWARD | Aprea Therapeutics, Inc. | 329,000 | 0.00 USD | deriv |
| 13 May 2020 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 4,218 | 0.00 USD | |
| 13 May 2020 | GRANT_AWARD | INTEGRA LIFESCIENCES HOLDINGS CORP | 791 | 0.00 USD | |
| 24 Mar 2020 | GRANT_AWARD | Aprea Therapeutics, Inc. | 127,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 18 May 2022.